Differential Expression and Prognostic Correlation of Immune Related Factors Between Right and Left Side Colorectal Cancer

Overview

Journal Front Oncol

Specialty Oncology

Date 2022 Aug 8

PMID 35936748

Authors

Yue Hu

Jie Ding

Chengjiang Wu

Hong Gao

Meiling Ge

Qixiang Shao

Yanhong Liu

Qing Ye

Affiliations

Soon will be listed here.

Abstract

Background: Growing evidence suggests that colorectal cancer (CRC) should be considered a heterogeneous disease. The right side (RCC) and left side (LCC) colorectal cancer have different clinical characteristics and immune landscapes. The aim of this study was to analyze differential expression and prognostic correlation of immune-related factors between RCC and LCC.

Methods: The gene expression profile and clinical characteristics of CRC patients were retrieved from The Cancer Genome Atlas data portal (n=525). Using a deconvolution algorithm, immune cell infiltration in RCC and LCC based on the RNA-seq data was analyzed. Differentially expressed genes (DEGs) were obtained by performing differential gene expression analysis. Immune-related DEGs were derived by the intersection with immune-related factors downloaded from the IMMPORT database. To further validate the findings, we applied immunohistochemical (IHC) staining of a CRC tissue microarray (TMA). The distribution of immune cells in RCC and LCC and changes in the expression of immune molecules on their membranes were verified. The expression levels of circulating cytokines were measured by flow cytometry to detect the cytokines secreted by immune cells in RCC and LCC. Furthermore, to reveal the prognostic value of differential immune factors on RCC and LCC patients, survival analysis based on mRNA levels using TCGA cohort and survival analysis using protein levels was performed using our CRC patients.

Results: The infiltration of immune cells differed between RCC and LCC, the infiltration degree of macrophages M0 was significantly higher in LCC, while the infiltration degree of differentiated macrophages M1 and M2, CD4+ T and CD8+ T cells was significantly higher in RCC. The expression of related molecules by immune cells also differed between RCC and LCC. The expression of 7 genes in RCC was higher than that in LCC, which were CCR5, CD209, CD8A, HCK, HLA-DPB1, HLA-DQA1, HLA-DRA, respectively. Meanwhile, the expression of 2 genes in LCC was higher than in RCC, which were IL-34 and PROCR. Patients with RCC having high expression of HLA-DQA1 mRNA or proteins had better survival and LCC patients with high expression of IL 34 mRNA or protein had better survival.

Conclusions: In this study, we comprehensively compared differences in immune cells and regulating factors between left and right colorectal cancer. Different expression patterns and their effects on survival were identified. The analysis of immune-related factors may provide a theoretical basis for precise immunotherapy of RCC and LCC.

Citing Articles

Identification and validation of a CD4 T cell-related prognostic model to predict immune responses in stage III-IV colorectal cancer.

Li M, Zhu W, Lu Y, Shao Y, Xu F, Liu L BMC Gastroenterol. 2025; 25(1):153.

PMID: 40069612 PMC: 11895157. DOI: 10.1186/s12876-025-03716-2.

Preoperative contrast-enhanced CT imaging and clinicopathological characteristics analysis of mismatch repair-deficient colorectal cancer.

Chen S, Du W, Cao Y, Kong J, Wang X, Wang Y Cancer Imaging. 2023; 23(1):97.

PMID: 37828626 PMC: 10568855. DOI: 10.1186/s40644-023-00591-6.

References

Worthley D, Leggett B . Colorectal cancer: molecular features and clinical opportunities. Clin Biochem Rev. 2010; 31(2):31-8. PMC: 2874430. View

Kobayashi T, Baghdadi M, Han N, Murata T, Hama N, Otsuka R . Prognostic value of IL-34 in colorectal cancer patients. Immunol Med. 2019; 42(4):169-175. DOI: 10.1080/25785826.2019.1691429. View

Hoekstra M, Bornes L, Dijkgraaf F, Philips D, Pardieck I, Toebes M . Long-distance modulation of bystander tumor cells by CD8 T cell-secreted IFNγ. Nat Cancer. 2020; 1(3):291-301. PMC: 7305033. DOI: 10.1038/s43018-020-0036-4. View

Iacopetta B . Are there two sides to colorectal cancer?. Int J Cancer. 2002; 101(5):403-8. DOI: 10.1002/ijc.10635. View

Ye L, Zhang T, Kang Z, Guo G, Sun Y, Lin K . Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer. Front Immunol. 2019; 10:2368. PMC: 6811516. DOI: 10.3389/fimmu.2019.02368. View

Plundrich D, Chikhladze S, Fichtner-Feigl S, Feuerstein R, Briquez P . Molecular Mechanisms of Tumor Immunomodulation in the Microenvironment of Colorectal Cancer. Int J Mol Sci. 2022; 23(5). PMC: 8910988. DOI: 10.3390/ijms23052782. View

Ren N, Liang B, Li Y . Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets. Biosci Rep. 2020; 40(10). PMC: 7560520. DOI: 10.1042/BSR20200980. View

Roth A, Delorenzi M, Tejpar S, Yan P, Klingbiel D, Fiocca R . Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer. J Natl Cancer Inst. 2012; 104(21):1635-46. DOI: 10.1093/jnci/djs427. View

Carethers J . One colon lumen but two organs. Gastroenterology. 2011; 141(2):411-2. PMC: 3424279. DOI: 10.1053/j.gastro.2011.06.029. View

10.

Giorello M, Matas A, Marenco P, Davies K, Borzone F, de Lujan Calcagno M . CD1a- and CD83-positive dendritic cells as prognostic markers of metastasis development in early breast cancer patients. Breast Cancer. 2021; 28(6):1328-1339. DOI: 10.1007/s12282-021-01270-9. View

11.

Qian Z, Huang L, Zhu X . An immunohistochemical study of CD83- and CD1a-positive dendritic cells in the decidua of women with recurrent spontaneous abortion. Eur J Med Res. 2015; 20:2. PMC: 4301856. DOI: 10.1186/s40001-014-0076-2. View

12.

Newman A, Steen C, Liu C, Gentles A, Chaudhuri A, Scherer F . Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019; 37(7):773-782. PMC: 6610714. DOI: 10.1038/s41587-019-0114-2. View

13.

Grady W, Pritchard C . Molecular alterations and biomarkers in colorectal cancer. Toxicol Pathol. 2013; 42(1):124-39. PMC: 3947043. DOI: 10.1177/0192623313505155. View

14.

Shen F, Pan Y, Li J, Zhao F, Yang H, Li J . High expression of HLA-DQA1 predicts poor outcome in patients with esophageal squamous cell carcinoma in Northern China. Medicine (Baltimore). 2019; 98(8):e14454. PMC: 6408075. DOI: 10.1097/MD.0000000000014454. View

15.

Grosche L, Knippertz I, Konig C, Royzman D, Wild A, Zinser E . The CD83 Molecule - An Important Immune Checkpoint. Front Immunol. 2020; 11:721. PMC: 7181454. DOI: 10.3389/fimmu.2020.00721. View

16.

Ishihara S, Watanabe T, Akahane T, Shimada R, Horiuchi A, Shibuya H . Tumor location is a prognostic factor in poorly differentiated adenocarcinoma, mucinous adenocarcinoma, and signet-ring cell carcinoma of the colon. Int J Colorectal Dis. 2011; 27(3):371-9. DOI: 10.1007/s00384-011-1343-0. View

17.

Booker B, Clark R, Pellom S, Adunyah S . Interleukin-34 induces monocytic-like differentiation in leukemia cell lines. Int J Biochem Mol Biol. 2015; 6(1):1-16. PMC: 4443290. View

18.

Zhang L, Zhao Y, Dai Y, Cheng J, Gong Z, Feng Y . Immune Landscape of Colorectal Cancer Tumor Microenvironment from Different Primary Tumor Location. Front Immunol. 2018; 9:1578. PMC: 6048410. DOI: 10.3389/fimmu.2018.01578. View

19.

Siegel R, Miller K, Fedewa S, Ahnen D, Meester R, Barzi A . Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017; 67(3):177-193. DOI: 10.3322/caac.21395. View

20.

Ben-Baruch A . Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Res. 2003; 5(1):31-6. PMC: 154133. DOI: 10.1186/bcr554. View